Belén P. Solans

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis”.

Longitudinal Model-Based Biomarker Analysis of Exposure-Response Relationships in Adults with Pulmonary Tuberculosis

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01794-20

N/A

0.571DataRank · unranked

12 citations

Belén P. Solans, William R. Mac Kenzie, Chad Heilig, William C. Whitworth, John L. Johnson +5 more

Pharmacokinetics and Safety of Bedaquiline in Human Immunodeficiency Virus (HIV)-Positive and Negative Older Children and Adolescents With Rifampicin-Resistant Tuberculosis

Clinical Infectious Diseases(2022)10.1093/cid/ciac252

N/A

0DataRank · unranked

15 citations

Belén P. Solans, Heather R. Draper, H. Simon Schaaf, Jana Winckler, L. van der Laan +7 more

Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation

Pharmaceutics(2022)10.3390/pharmaceutics14112462

N/A

0DataRank · unranked

14 citations

Belén P. Solans, Ying Lü, Sandhya Kharbanda, Christopher C. Dvorak, Nahal Lalefar +10 more

Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure

Clinical Infectious Diseases(2022)10.1093/cid/ciac001

N/A

0DataRank · unranked

12 citations

Adrie Bekker, Belén P. Solans, Mark F. Cotton, Mark Mirochnick, Avy Violari +8 more

QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.01448-22

N/A

0DataRank · unranked

10 citations

Kendra K. Radtke, Anneke C. Hesseling, Jana Winckler, H. Simon Schaaf, Heather R. Draper +8 more

Pharmacokinetics and cardiac safety of clofazimine in children with rifampicin-resistant tuberculosis

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00794-23

N/A

0DataRank · unranked

9 citations

Belén P. Solans, Anneke C. Hesseling, Jana Winckler, H. Simon Schaaf, Heather R. Draper +8 more

Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children

Clinical Infectious Diseases(2021)10.1093/cid/ciab641

N/A

0DataRank · unranked

31 citations

Anneke C. Hesseling, Jana Winckler, Heather R. Draper, Belén P. Solans, Stephanie Thee +8 more

Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis

Clinical Infectious Diseases(2024)10.1093/cid/ciae024

N/A

0DataRank · unranked

13 citations

Belén P. Solans, Paolo Denti, Louvina E. van der Laan, H. Simon Schaaf, Bryan Vonasek +7 more